PAN hires new associate director and head of Art
October 10, 2013Medical Communications, Research and Development, Sales and Marketing Pan, burchell, ohare, reiss
Creative agency PAN has strengthened its senior team with the arrival of Jan Reiss as associate director and the promotion …
NHS ‘behind the curve’, warns government
October 10, 2013Medical Communications, Sales and Marketing NHS, curve, technology
The government is on track to deliver a paperless NHS by 2018, according to parliamentary undersecretary of state for health …
Sanofi appoints senior vice president
October 10, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, warnery
Vincent Warnery has been appointed as the senior vice president to Sanofi’s new Global Consumer Healthcare Division. He will remain …
Lilly staff ‘divulged secrets’
October 10, 2013Medical Communications, Sales and Marketing China, bribery, lilly
Two former staff from Eli Lilly & Company have been accused in a US court of passing on industrial secrets …
Life makes senior changes
October 10, 2013Medical Communications Life Healthcare
Marketing comms agency Life has restructured as several senior personnel change their positions and titles. Reg Manser is leaving his …
Janssen takes on GSK hep C drug
October 9, 2013Research and Development, Sales and Marketing GSK, GSK2336805, HCV, Janssen
Janssen Pharmaceuticals has acquired one of GlaxoSmithKline’s investigational hepatitis C treatments and will look at it in combination with various …
SMC must be ‘more flexible’ – health minister
October 9, 2013Sales and Marketing CDF, NICE, SMC
The Scottish health secretary Alex Neil has announced a series of fundamental changes to improve access to new medicines in …
Bayer pill gains FDA approval despite shutdown
October 9, 2013Sales and Marketing Bayer, FDA, adempas, hypertension
In the midst of the US shutdown of government agencies the FDA has managed to approve Bayer’s Adempas for patients …
Three hires for RSA
October 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interim, life sciences, rsa
Life sciences executive search and interim management firm RSA has made three appointments to its European team. Elmar Scheuba has …
Nobel Prize could point to diabetes treatment
October 9, 2013Research and Development, Sales and Marketing James Rothman, Randy Schekman, Thomas Südhof, nobel
The Nobel Prize for medicine or physiology has been won jointly by three scientists whose research has uncovered the mechanism …
EMA bows to pressure on its own transparency
October 8, 2013Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Guido Rasi, transparency
The European Medicines Agency (EMA)’s management board has agreed to publish agendas and minutes from the meetings of all the …
GSK sets malaria vaccine roll-out date to 2015
October 8, 2013Research and Development, Sales and Marketing GSK, Vaccine, malaria, rts, s
GlaxoSmithKline says it is just two years away from marketing the world’s first malaria vaccine RTS,S. This follows results from …
Aesica gets bigger in pre-filled syringes
October 8, 2013Manufacturing and Production Aesica, CDMO, pre-filled syringe
UK contract development and manufacturing organisation Aesica is expanding production capacity for pre-filled syringes at its plant in Nottingham to …
Red Door Communications appoints three managers
October 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Red Door Communications
Comms agency Red Door Communications (RDC) has strengthened its consultancy team with the appointment of three new senior account managers. …
New UK drug pricing plans ‘delayed’
October 7, 2013Medical Communications, Sales and Marketing Drug pricing, Hunt, Lansley, NHS, NICE, VBP
1,100 jobs to go as Ben Venue confirms closure of Bedford unit
October 7, 2013Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, FDA
Boehringer Ingelheim is calling time on its troubled facility in Ohio operated by Ben Venue Laboratories and says it will …
EMA gets first line Arzerra submission
October 7, 2013Sales and Marketing Arzerra, GSK, Genmab, blood cancer
GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the European Medicines Agency (EMA) in a first line …
‘Kick in the teeth’ for NHS
October 7, 2013Sales and Marketing Hunt, NHS, burnham
The UK Labour party has hit back at a government move to scrap a 1% pay rise for more than …
Labour may sue Hunt over ‘cover-up’ tweet
October 7, 2013Medical Communications, Sales and Marketing Hunt, Labour, NHS, Twitter, cover up
The Labour Party is considering suing the health secretary Jeremy Hunt over an alleged libellous Twitter post made on the …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
Highlighting the value of lab research for healthcare innovation
